Clinical Trial Detail

NCT ID NCT03416153
Title Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Michigan Cancer Center
Indications

oropharynx cancer

Therapies

Cetuximab

Age Groups: senior adult

Additional content available in CKB BOOST